Related Experiment Videos
Effects of pharmacological treatment of acute myocardial infarction on left ventricular function
M Chiariello1, P Golino, G Ambrosio
1Department of Medicine, 2nd School of Medicine, University of Naples, Italy.
Insights
Acute myocardial infarction impairs left ventricular function. Early reperfusion therapy improves outcomes, but reperfusion injury can occur, potentially mitigated by free radical scavengers.
Area of Science:
- Cardiology
- Cardiovascular Research
- Myocardial Infarction Research
Background:
- Left ventricular function impairment is a key outcome of acute myocardial infarction (AMI).
- Traditional therapies (beta-blockers, nitrates) reduce mortality but show limited benefit for left ventricular function.
- Early reperfusion via thrombolysis has become standard for AMI, improving infarct size and ventricular function.
Purpose of the Study:
- To evaluate the impact of early reperfusion on left ventricular function post-AMI.
- To investigate the phenomenon of reperfusion-mediated myocardial injury.
- To explore potential therapeutic strategies, such as free radical scavengers, to mitigate reperfusion injury.
Main Methods:
- Review of experimental preparations and clinical trials on acute myocardial infarction treatments.
- Analysis of the effects of thrombolytic agents on myocardial tissue.
- Investigation into the role of oxygen metabolites in reperfusion injury.
Main Results:
- Early reperfusion significantly reduces infarct size and improves left ventricular function in AMI patients.
- Reperfusion can paradoxically cause tissue damage, potentially negating its benefits.
- Experimental studies suggest free radical scavengers can reduce reperfusion injury and enhance contractile recovery.
Conclusions:
- Early reperfusion is a critical intervention for acute myocardial infarction, improving cardiac function and survival.
- Reperfusion injury, mediated by oxygen metabolites, is a significant concern that can blunt therapeutic benefits.
- Targeting reperfusion injury with agents like free radical scavengers holds promise for optimizing AMI treatment outcomes.
Abstract:
Impairment of left ventricular function is a major consequence of acute myocardial infarction. Several interventions have been proposed to reduce the extent of myocardial tissue undergoing necrosis after cornoracy artery occlusion. Therapy for patients with acute myocardial infarction has long relied on interventions aimed at reducing oxygen consumption, such as administration of beta-blockers and nitrates. However, despite clinical evidence that these interventions can reduce mortality or prevent left ventricular dilatation, no clear benefit has been observed on left ventricular function. Over the past few years, treatment of acute myocardial infarction has radically changed. Availability of several thrombolytic agents has made reperfusion of ischemic myocardium a routine procedure. Early reperfusion has been shown to be the most powerful intervention to reduce infarct size and minimize left ventricular dysfunction in experimental preparations. Several clinical trials have also demonstrated that patients with acute myocardial infarction may greatly benefit from early thrombolysis, as this procedure is associated with improvement of global and regional left ventricular function and reduction in mortality. However, in spite of its obvious advantages, reperfusion might result in a paradoxical tissue damage that may blunt the net beneficial effect of restoring perfusion of ischemic myocardium. Reperfusion-mediated myocardial injury has been shown to occur in several experimental preparations and it has been proposed that generation of toxic oxygen metabolites at the moment of reflow is responsible for the occurrence of this phenomenon. Indeed, administration of free radical scavengers may significantly reduce the extent of reperfusion injury and improve contractile recovery in experimental preparations.(ABSTRACT TRUNCATED AT 250 WORDS)